AskNiveshLive·12:13 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to ZYDUSLIFE

Zydus Lifesciences Ltd.: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsMar-25Jun-25Sep-25Dec-25Mar-26
Revenue
6,5286,5746,1236,8647,587
Other income
81155109111134
Segment revenue (incl. inter-segment)
6,5286,5746,1236,8647,587
Expenses
4,7174,8084,5115,5385,664
Cost of materials consumed
1,1641,2191,3271,2161,347
Purchases of stock-in-trade
573658589852972
Change in inventories
-40-88-226-232-343
Employee benefit expense
9711,0051,0341,1401,239
Finance costs
7785101130123
Depreciation & amortisation
238238302360508
Other expenses
1,7341,6901,3832,0721,818
EBITDA
1,9872,2442,0901,8432,291
EBIT
1,7492,0061,7881,4831,783
Operating profit
1,8921,9211,7221,4382,057
Exceptional items
-220--34-85-398
Profit Before Tax
1,6721,9211,6871,3531,660
Tax expense
423434454388318
Deferred tax
-56720375144-207
Net Profit
1,2441,5211,2391,0231,341
Financial Ratios
Operating Profit Margin
28.98%29.22%28.12%20.95%27.11%
EBITDA Margin
30.43%34.13%34.13%26.85%30.20%
Net Profit Margin
19.06%23.14%20.24%14.90%17.67%
Earnings Per Share (₹)
11.6414.5812.5110.3612.65

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.